Published in Cancer Weekly, June 5th, 2006
"Correct diagnosis of the tissue origin of a metastatic cancer is the first step in disease management, but it is frequently difficult using standard pathologic methods. Microarray-based gene expression profiling has shown great promise as a new tool to address this challenge. Adoption of microarray technologies in the clinic remains limited," wrote X.J. Ma and colleagues, Arcturus BioScience Inc.
"We aimed to bridge this technological gap by developing a RT-PCR assay. We...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.